Few supplements are argued over as fiercely as vitamin D. One side says most adults in northern countries are deficient, that low levels are linked to weak bones, infections, depression and several cancers, and that a daily pill is cheap insurance. The other says most healthy adults get what they need anyway, that the big trials on supplements mostly came back empty, and that blood tests are driving millions of people to take a pill they do not need. This follows our usual format of setting out what both sides claim and then checking the sources, rated with our 5-star ranking system. Here is what each side claims and what the evidence shows when you check it.
What the pro-supplement side claims
The pro side starts with physiology. Vitamin D is made in the skin from sunlight, and in the UK and similar latitudes the sun is too weak to produce any from roughly October to March. People who work indoors, cover their skin, or have darker skin make less of it. Since few foods carry much vitamin D beyond oily fish, fortified products and eggs, the argument goes, a large share of adults run low or deficient for at least half the year.
They point to the links. Low blood vitamin D is associated with rickets and osteomalacia, and that much is settled. Beyond bones, observational studies have connected low levels to respiratory infections, depression, falls in older people, and several cancers. The recommended doses are small, 10 micrograms or 400 IU a day in the UK, and cost pennies. On this view, a supplement that is cheap and safe, taken by people who are likely low anyway, is sensible insurance, and the UK government already advises everyone to consider an autumn and winter supplement.
What the sceptical side claims
Sceptics do not dispute that severe deficiency causes disease. Their argument is about the healthy adults targeted by testing and supplement marketing. The big randomised trials, they note, have repeatedly failed to confirm what the observational studies promised. Large trials of vitamin D against cancer and cardiovascular disease, including the VITAL trial of nearly 26,000 US adults, found no meaningful reduction in either. A large trial in acute respiratory infection found only a small overall benefit, concentrated in people who were genuinely deficient.
They also warn about the testing spiral. Blood thresholds for “sufficiency” are debated, many labs set the bar high enough that most healthy people fail it, and the result is a nation treated for a lab value rather than a symptom. On this view, healthy adults with no bone risk factors should not be tested, and if they take anything, the small 400 IU winter dose recommended by public bodies, not the high-dose regimens sold online.
What the strongest sources actually show
Put together, the evidence supports a narrow version of each claim:
- Severe deficiency causes bone disease, and people at risk of it benefit from supplementation. This includes older adults, people who rarely go outdoors, people with darker skin at high latitudes, and those with malabsorption conditions.
- In healthy adults who are not deficient, trials show little or no benefit against cancer, heart disease, depression or infections.
- A winter dose of around 400 IU a day is what public bodies in the UK actually recommend for the general population, and high monthly doses have performed worse than daily small ones in some trials.
| Claim | Best source available | What it found | Evidence rating |
|---|---|---|---|
| Severe deficiency causes bone disease | Long-standing clinical observation and trials in deficient patients | Supplementation reverses and prevents rickets and osteomalacia | ★★★★★ |
| High-dose vitamin D prevents cancer or heart disease in healthy adults | VITAL randomised trial, ~26,000 adults | No significant reduction in either outcome | ★★★★☆ |
| Supplements reduce winter respiratory infections | Large randomised trial, 25,000 adults | Small overall effect, mainly in people who were deficient at baseline | ★★★★☆ |
| Most UK adults are low in winter | National diet and nutrition surveys | A substantial share fall below target levels in winter months | ★★★☆☆ |
| Low vitamin D causes depression or fatigue in healthy adults | Randomised trials of supplementation | Little consistent effect in people not deficient | ★★★☆☆ |
We rated the trial findings higher than the survey data because randomised trials can separate cause from correlation, while blood-level surveys cannot. The pattern here is the same one we found when we examined what both sides claim about statins for healthy adults: strong evidence for the people who are genuinely at risk, weak evidence for the worried well.
The dosing argument
The two sides also disagree about how the pill is taken. Many supplement sellers push 2,000 to 4,000 IU a day or more, often after a blood test shows a level in the 40s. Sceptics point to trials of high intermittent doses, such as very large monthly bolus regimens given to older adults for fall prevention, which performed worse than daily doses and in one case slightly increased falls. The pro side replies that those bolus trials used extreme regimens nobody recommends, and that daily doses of 1,000 to 2,000 IU have a long safety record, with the tolerable upper limit set at 4,000 IU a day by US and European food safety bodies. Both claims can be checked: the bolus trial data is public, and so are the upper-limit reports from the food safety authorities.
One practical point both sides concede: vitamin D is fat-soluble, so it should be taken with a meal containing some fat, and the same dose raises blood levels differently in people with higher body weight. Trials that ignore weight tend to blur their own results, which is one reason the observational and trial findings have clashed so often.
Truza presents both claims and the sources behind them. We do not tell anyone what to take. The sources above are the ones each side rests on, and readers can weigh them.